carbapenems has been researched along with aztreonam in 36 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (aztreonam) | Trials (aztreonam) | Recent Studies (post-2010) (aztreonam) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 1,564 | 234 | 355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (11.11) | 18.2507 |
2000's | 6 (16.67) | 29.6817 |
2010's | 14 (38.89) | 24.3611 |
2020's | 12 (33.33) | 2.80 |
Authors | Studies |
---|---|
Anderson, DJ | 1 |
Butler, K; Gress, J; Lecciones, J; Lee, J; Marshall, D; Pizzo, PA; Roilides, E; Rubin, M; Walsh, T; Weinberger, M | 1 |
Awaya, Y; Fujiue, Y; Kodomari, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y | 1 |
Kinoshita, S; Kumagai, S | 1 |
Stock, I; Wiedemann, B | 1 |
Hashimoto, H; Horii, T; Kanno, T; Maekawa, M; Morita, M; Muramatsu, H | 1 |
Daikos, GL; Loli, A; Miriagou, V; Panagiotakopoulou, A; Tzelepi, E; Tzouvelekis, LS | 1 |
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
Deptuła, A; Gierlotka, K; Gospodarek, E; Michalska, A | 1 |
Brémont, S; Conroy, MC; Courvalin, P; Lambert, T; Moubareck, C | 1 |
Hsueh, PR; Ko, WC; Lu, JJ; Teng, LJ; Wang, FD; Wu, HY; Wu, JJ; Wu, TL | 1 |
Bogaerts, P; Bouchahrouf, W; de Castro, RR; Denis, O; Deplano, A; Glupczynski, Y; Tsobo, C | 1 |
Antunes, NT; Frase, H; Lamoureaux, TL; Vakulenko, SB | 1 |
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
Docquier, JD; Luzzaro, F; Maradei, S; Olivo, G; Pecile, P; Pollini, S; Rossolini, GM | 1 |
Bonomo, RA; June, CM; Kaitany, KC; Klinger, NV; Leonard, DA; Powers, RA; Ramey, ME | 1 |
Alonzi, C; Caruso, C; Gaeta, F; Maggioletti, M; Romano, A; Valluzzi, RL | 1 |
Srinivas, NR | 1 |
Boyd, D; Carpenter, M; Desruisseau, A; Janecko, N; Mangat, CS; Martz, SL; Mulvey, MR; Reid-Smith, RJ | 1 |
Cicek, AC; Duzgun, AO; June, CM; Leonard, DA; Sandalli, C; Saral, A | 1 |
Fujita, J; Kirikae, T; Miyazato, Z; Nakasone, I; Shimada, K; Shinzato, T; Tada, T; Tsuchiya, M; Uechi, K | 1 |
Hsu, AJ; Tamma, PD | 1 |
Li, J; Ma, W; Sun, S; Wang, D; Yu, C | 1 |
Antunes, VU; Doucet, N; Farah, CS; Favaro, DC; Lincopan, N; Llontop, EE; López de Los Santos, Y; Mittermaier, A; Oliveira, RJ; Vasconcelos, FNDC | 1 |
Ashraf, T; Barathan, G; Darwish, D; Ghazawi, A; Hashmey, R; Pál, T; Rizvi, TA; Sonnevend, Á | 1 |
Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
Chen, Y; Ji, J; Liu, Z; Luo, Q; Xiao, Y; Xiong, L; Ying, C; Yu, W | 1 |
Albur, M; Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR | 1 |
Bai, F; Chen, S; Cheng, Z; Jin, Y; Pan, X; Wei, X; Wu, W; Xu, C | 1 |
Cai, H; Chen, M; Hua, X; Li, Y; Sun, R; Wang, N; Yu, Y; Zhang, P | 1 |
Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y | 1 |
Axelrod, P; Holaday, E; Mishkin, A; Motzer, AR | 1 |
Kader, O; Rezk, S; Shawky, S; Taha, R | 1 |
Chen, J; Jia, W; Jing, R; Li, J; Liu, Y; Sun, G; Sun, H; Wang, T; Xu, X; Xu, Y; Zhang, G | 1 |
Kamat, S; Karlowsky, JA; Mohamed, N; Sahm, DF; Wise, MG | 1 |
Feng, Y; Ma, K; McNally, A; Zong, Z | 1 |
4 review(s) available for carbapenems and aztreonam
Article | Year |
---|---|
Choosing the right antibacterial agent. Is 'newer' always better?
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Ciprofloxacin; Humans; Microbial Sensitivity Tests | 1991 |
The febrile neutropenic patient: newer options for empirical therapy.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Neutropenia; Quinolones | 1990 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems.
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cystic Fibrosis; Disease Progression; Humans; Pseudomonas Infections | 2012 |
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam | 2019 |
32 other study(ies) available for carbapenems and aztreonam
Article | Year |
---|---|
[The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serotyping; Sputum; Thienamycins | 1998 |
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins | 1998 |
beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium.
Topics: Animals; Aztreonam; beta-Lactams; Carbapenems; Cephalosporins; Culture Media; Dogs; Humans; Microbial Sensitivity Tests; Penicillins; Plesiomonas | 2001 |
Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.
Topics: Amino Acids, Basic; Anti-Bacterial Agents; Aztreonam; Carbapenems; Ceftazidime; Culture Media; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Thienamycins | 2003 |
Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Greece; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
[Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2007 |
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Carbapenems; Integrons; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Plasmids | 2009 |
Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan.
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Guideline Adherence; Laboratories; Microbial Sensitivity Tests; Taiwan | 2010 |
Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece.
Topics: Adult; Aztreonam; beta-Lactamases; Carbapenems; Colistin; Female; Gentamicins; Greece; Humans; Klebsiella pneumoniae; Medical Tourism; Minocycline; Plasmids; Tigecycline | 2011 |
Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6.
Topics: Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Carbapenems; Cephalosporins; Escherichia coli; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Penicillins; Substrate Specificity | 2012 |
FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cloning, Molecular; Enzyme Assays; Escherichia coli; Gene Transfer Techniques; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Penicillins; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Alignment; Substrate Specificity | 2013 |
Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.
Topics: Acinetobacter; Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Crystallography, X-Ray; Doripenem; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2013 |
Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Carbapenems; Cross Reactions; Drug Hypersensitivity; Drug Substitution; Female; Humans; Hypersensitivity, Immediate; Immune Tolerance; Male; Middle Aged; Penicillins; Skin Tests; Young Adult | 2015 |
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin | 2016 |
Characterization of VCC-1, a Novel Ambler Class A Carbapenemase from Vibrio cholerae Isolated from Imported Retail Shrimp Sold in Canada.
Topics: Amino Acid Sequence; Animals; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Canada; Carbapenems; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Penaeidae; Penicillanic Acid; Penicillins; Seafood; Sequence Alignment; Sequence Analysis, DNA; Tazobactam; Vibrio cholerae | 2016 |
Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Hydrolysis; Mutation; Penicillins; Plasmids; Protein Conformation; Substrate Specificity; Turkey | 2016 |
A hemin auxotrophic Enterobacter cloacae clinical isolate with increased resistance to carbapenems and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Hemin; Humans; Japan; Sequence Deletion | 2018 |
In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefoperazone; Ceftazidime; China; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2019 |
Importance of the β5-β6 Loop for the Structure, Catalytic Efficiency, and Stability of Carbapenem-Hydrolyzing Class D β-Lactamase Subfamily OXA-143.
Topics: Acinetobacter baumannii; Ampicillin; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Hydrolysis; Kinetics; Models, Molecular; Molecular Dynamics Simulation; Mutation, Missense; Oxacillin; Protein Conformation, beta-Strand; Protein Stability; Substrate Specificity | 2019 |
In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Middle East; Tigecycline | 2020 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Microbial Sensitivity Tests; Sepsis | 2021 |
Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Piperacillin; Pseudomonas aeruginosa; Tazobactam | 2022 |
Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Collateral Sensitivity; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Porins; Protease La; Proteomics; Tetracyclines | 2022 |
Plasmid-Borne AFM Alleles in Pseudomonas aeruginosa Clinical Isolates from China.
Topics: Alleles; Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Clostridium Infections; Drug Hypersensitivity; Fluoroquinolones; Humans; Hypersensitivity; Lung; Pneumonia; Retrospective Studies; Transplant Recipients | 2022 |
Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Escherichia coli; Humans; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefepime; Microbial Sensitivity Tests; Tigecycline | 2023 |
In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021.
Topics: Anti-Bacterial Agents; Asia; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Humans; Latin America; Microbial Sensitivity Tests; Middle East | 2023 |
Hijacking a small plasmid to confer high-level resistance to aztreonam-avibactam and ceftazidime-avibactam.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Escherichia coli; Microbial Sensitivity Tests; Plasmids | 2023 |